IntelliPlex Digital Multiplex Assay Development

About GeneMed Biotechnologies

GeneMed Biotechnologies is an established, privately-held player in the diagnostics and life sciences research tools sector, operating from San Francisco. The company leverages a diversified business model combining product sales with contract services, focusing on tissue-based diagnostics (IHC/ISH), molecular diagnostics (PCR components, multiplex assays), and functional recombinant proteins. Its core strengths lie in reagent manufacturing expertise, a growing digital multiplex platform (IntelliPlex/DigiPlex), and a service-oriented approach for OEM and IVD partners. While not a therapeutic developer, GeneMed occupies a critical niche as an enabler for research and diagnostic assay commercialization.